Effect of Radial Extracorpeal Shock Wave on Pain and Function
Hemiplegia
About this trial
This is an interventional treatment trial for Hemiplegia focused on measuring pain thrshold, ROM
Eligibility Criteria
Inclusion Criteria:
- Patient's age ranges from 40 to 60 years.
- Spasticity of upper limb ranges from mild to moderate (grade 1+: 2) according to modified aschworth scale (MAS).
- Patients with sufficient cognitive abilities that enables them to understand and follow instructions (Mini-Mental Scale >24).
- Patient who understand the study process and signed the informed consent form.
- Patient with stroke more than 3 months ago.
8. Patient with shoulder pain and limited range of motion (ROM) or loss of motion in the proximal arm on the hemiplegic side.
Exclusion Criteria:
1. Patients who cannot express their own pain intensity. 2. Patients with a history of trauma or surgery to the shoulder on the affected side.
3. Patients with history of oral NSAIDs 3 days before this study or take warfarin medication with an international normalized ratio above 4.0.
4. Patients with a history of shoulder pain before the stroke. 6. Patients who have received a previous shoulder intra-articular injection or other interventions on the affected shoulder within one month before rESWT.
7. Patients with cardiac pacemaker. 8. Patients who have osteoporosis. 9. Patients with psychological problems.
Sites / Locations
- Cairo university
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
study group
control group
Patients will received 3,000 pulses, 1,500 pulses per site at a frequency of 12 Hz per session with the submaximal pressure between 0.39 and 1.95 mJ/mm2 (1.0 and 5.0 bar), depending on the level which the patient can tolerate without local anesthetics.
The patients in this group will be treated by sham radial extracorporeal shock wave therapy